Tagrisso Osimertinib 80mg and 40mg Strengths and USA Ordering
Author: Dr. James Nakamura
On September 2, 2026, EGFR lung cancer societies updated patient guidelines on Osimertinib strengths. EGFR-mutant lung cancer patients often require Tagrisso (Osimertinib). Learn about the 80mg and 40mg strengths, how to order them, and storage guidelines. Access Tagrisso 80mg and Tagrisso 40mg. Osimertinib blocks cancer cell signals to halt tumor growth in EGFR-mutant NSCLC.
Standard Strengths Overview
- Tagrisso 80mg: Standard daily starting dose for most NSCLC cases.
- Tagrisso 40mg: Used primarily for dosage reductions under oncologist guidance.
